Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Adenocarcinoma: Advanced NSCLC

Join Jeffrey Bradley, MD (Radiation Oncology), Ramaswamy Govindan, MD (Medical Oncology), and Peter Humphrey, MD, PhD (Surgical Pathology) as they present their multidisciplinary expertise on a range of cases pertaining to advanced adenocarcinoma.

Since patients are heterogeneous, patient management should also be individualized. The cases in this webinar are designed to highlight significant clinical decision points concerning treatment selection, toxicity management, and areas of recent change or controversy in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) while reinforcing emerging data from clinical trials. This webinar will allow learners to understand how to apply the standards of care to their practice and healthcare setting.

Most patients with NSCLC have advanced disease (stage IIIB or IV) at diagnosis. Studies show that histology, mutation testing, and other criteria can be used to select the most appropriate systemic therapy for these patients. NSCLC is typically divided into two categories: nonsquamous and squamous cell carcinomas. For nonsquamous, adenocarcinoma is the most common histology. Patients with adenocarcinoma or large cell carcinoma have improved survival when treated with cisplatin and pemetrexed, whereas those with squamous cell carcinoma have improved survival when treated with cisplatin and gemcitabine. Carboplatin/paclitaxel/bevacizumab is another chemotherapy regimen for select patients with advanced NSCLC (i.e., nonsquamous NSCLC, no hemoptysis).

The NCCN Guidelines recommend a multidisciplinary approach for patients with NSCLC so that treatment can be tailored for individual patients, which will improve outcomes by decreasing toxicity, increasing quality of life, and increasing survival. Oncologists need to be aware of the most recent updates about molecular testing and treatment so they can effectively manage their patients with NSCLC.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Apply NCCN Guideline-based therapeutic strategies for advanced adenocarcinoma in the treatment of patients.
  • Describe the multidisciplinary aspects of patient management for advanced adenocarcinoma.
  • Identify the key characteristics for advanced adenocarcinoma that trigger decision points.
  • Recognize situations where optimal care may require adapting the guideline recommendations to individual circumstances.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • Daiichi Sankyo, Inc.
  • Genentech
  • Millennium: The Takeda Oncology Company
  • Novartis Pharmaceuticals Corporation
  • Teva Pharmaceuticals

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

This activity is supported by a grant from Onyx Pharmaceuticals.

Course summary
Available credit: 
  • 0.75 Participation
  • 0.83 Nurse
  • 0.75 Pharmacist
  • 0.75 Physician
Course opens: 
07/02/2013
Course expires: 
07/02/2014
Cost:
$0.00

Jeffrey Bradley, MD
Siteman Cancer Center at Barnes-Jewish Hospital
and Washington University School of Medicine
St. Louis, Missouri


Ramaswamy Govindan, MD
Siteman Cancer Center at Barnes-Jewish Hospital
and Washington University School of Medicine
St. Louis, Missouri


Peter Humphrey, MD, PhD
Siteman Cancer Center at Barnes-Jewish Hospital
and Washington University School of Medicine
St. Louis, Missouri

Available Credit

  • 0.75 Participation
  • 0.83 Nurse
  • 0.75 Pharmacist
  • 0.75 Physician

Accreditation Period

Course opens: 
07/02/2013
Course expires: 
07/02/2014

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Flash Player and/or an HTML5 capable browser for video or audio playback
  • For Windows: JavaScript and cookies enabled, Active X enabled and unblocked for Microsoft Internet Explorer, Java 6.0 or above
  • For Mac: JavaScript and cookies enabled, Plug-ins enabled in Safari, Java 6.0 or above
  • Adobe Reader or other PDF reader software for certificate viewing/printing